Cancer patients

Cancer metastasis

Prognostic Factors Identified for Metastatic Castration-Resistant Prostate Cancer Undergoing Radioligand Therapy

New research conducted at the Department of Nuclear Medicine, Balikesir Ataturk City Hospital in Turkiye has shed light on the prognostic factors for metastatic castration-resistant prostate cancer (mCRPC) patients undergoing 177Lu-PSMA-617 radioligand therapy. The study retrospectively examined 31 patients with median age 69 (57-80) years, who received treatment between 2021

Cancer

Breakthrough in Cancer Treatment: American Oncology Institute Achieves Success with Hyperthermic Intraperitoneal Chemotherapy

The American Oncology Institute (AOI) at ASCOMS Jammu has made a significant stride in complex cancer treatment by successfully performing a Hyperthermic Intraperitoneal Chemotherapy (HIPEC) procedure on a patient with advanced ovarian cancer. This achievement highlights AOI Jammu's growing capabilities in delivering high-end cancer care and offering sophisticated